,204 Thus, IGF2BP1 has attracted attention for its potential to serve as a biomarker for diagnosis and prognosis for abovementioned cancers, as well as for other cancers including uveal melanoma, breast cancer, neuroblastoma, esophageal cancer, and cervical cancer.49 Here, IGF2BP1 is linked to cervical carcinoma.